Noah Rozich, MD
NOTE : If you're an existing patient, please connect via MyChart
-
About Me
About Noah Rozich, MD
Noah Rozich, MD, is an assistant professor in the Division of Surgical Oncology and Endocrine Surgery at UT San Antonio. He is a surgical oncologist who specializes in treating tumors of the digestive system and soft tissues. He provides surgical care for patients with cancers of the stomach, small intestine, liver, gallbladder, bile ducts and pancreas, developing individualized treatment plans based on each patient’s diagnosis and needs.
Dr. Rozich earned a Bachelor of Science from the University of Wisconsin-Madison and his medical degree from the University of Wisconsin School of Medicine and Public Health. He completed his general surgery residency at the University of Oklahoma Health Sciences Center in Oklahoma City.
During his training, Dr. Rozich dedicated two years to cancer research, including one year of National Institutes of Health-supported pancreatic cancer research in Lei Zheng’s laboratory at Johns Hopkins University. He then completed a fellowship in complex general surgical oncology at Aurora St. Luke’s Medical Center in Milwaukee.
His practice includes hyperthermic intraperitoneal chemotherapy, or HIPEC. This advanced treatment delivers a heated chemotherapy solution directly into the abdomen during surgery to treat certain cancers that have spread to the lining of the abdominal cavity. He also treats soft tissue sarcomas and performs complex abdominal surgeries, working closely with a multidisciplinary team of cancer specialists to coordinate each patient’s care.
Alongside his clinical practice, Dr. Rozich remains active in research focused on improving surgical care and outcomes for patients with pancreatic and other gastrointestinal cancers.
Dr. Rozich is committed to helping patients and their families understand their diagnosis, treatment options and what to expect before, during and after surgery. He provides clear guidance and individualized support throughout their care.
Gender
- Male
Languages Spoken
- English
-
Credentials
Credentials
Positions
- Assistant professor, Division of Surgical Oncology and Endocrine Surgery, The University of Texas at San Antonio
Certifications
- American Board of Surgery, General Surgery
- American Board of Surgery, Complex General Surgical Oncology
Education
- Medical School: University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
- Residency: General Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
- Research Fellowship: Surgical Research, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
- Research Fellowship: Surgical Research, Johns Hopkins University School of Medicine, Baltimore, Maryland
- Fellowship: Complex General Surgical Oncology, Aurora Advocate Health Care, Milwaukee, Wisconsin
- Undergraduate: Bachelor of Science in Molecular Biology, University of Wisconsin-Madison, Madison, Wisconsin
- Locations & Contact
-
Research & Publications
Research & Publications
Overcome the challenge for intratumoral injection of STING agonist for pancreatic cancer by systemic administration
Li, K., Wang, J., Zhang, R., Zhou, J., Espinoz, B., Niu, N., Wang, J., Jurcak, N., Rozich, N., Osipov, A., Henderson, M., Funes, V., Lyman, M., Blair, A., Herbst, B., He, M., Yuan, J., Trafton, D., Yuan, C., Wichroski, M., Liu, X., Fu, J., Zheng, L.
J Hematol Oncol 17, 62 (2024): 1-6.
Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model.
Li, P1., Rozich, NS1., Wang, J1., Wang, J., Xu, Y., Herbst, B., Yu, R., Muth, S., Niu, N., Li, K. and Funes, V.
Cancer Letters, p.215722.
CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma.
Wang J, Saung MT, Li K, Fu J, Fujiwara K, Niu N, Muth S, Wang J, Xu Y, Rozich N, Zlomke H, Chen S, Espinoza B, Henderson M, Funes V, Herbst B, Ding D, Twyman-Saint Victor C, Zhao Q, Narang A, He J, Zheng L.
J Exp Med. 2022 May 2;219(5):e20211631. doi: 10.1084/jem.20211631. Epub 2022 Apr 11. PMID: 35404390.
View all publications - Noah Rozich, MD
-
Clinical Trials
Clinical Trials
No Clinical Trials